First-in-human, FDA-approved clinical trial to test a hydrogel on cardiac tissue
Medical Xpress - 12-Sep-2019Positive results seen in patients who had a heart attack more than a year before
Ventrix
Company that produces biomaterial for cardiac repair for patients who had heart attack.
Ventrix was founded based on a new approach to tissue engineering, focusing on repairing the microenvironment. We have guided our first product, VentriGel, from concept to the clinic. We have focused on the science behind VentriGel and are passionate about improving the quality of life of cardiovascular disease patients.
Visit website: https://ventrixheart.com/
See also: 
University of California
- Public research university with 10 campuses and 5 medical centres
Details last updated 07-Nov-2019
Ventrix Creations
Ventrix News
